SCIENTIFIC BIOGRAPHY
Member of the editorial board of the journal "Baikal Medical Journal", Doctor of Medical Sciences, Professor Dmitry Nikolaevich Zaitsev
Dmitry Nikolaevich Zaitsev studied at the Chita State Medical Academy in the medical and preventive faculty from 1995 to 2001. From 2001 to 2002, he completed clinical internship at the Department of Faculty Therapy of the ChSMA, specializing in "Internal Medicine". From 2002 to 2005, he worked as a cardiologist in the intensive care unit of the cardiology department of City Clinical Hospital No. 1. In 2004, he defended his PhD thesis on "Pathogenetic significance of changes in the fatty acid composition of blood lipids and heart rate variability indices in patients with acute alcoholic myocardial infarction".
In 2005, he was accepted as an assistant at the Department of Faculty Therapy. From 2006 to 2009, he studied for a doctorate at the Department of Faculty Therapy. In 2013, he was transferred to the position of associate professor of the Department of Faculty Therapy at the State Budgetary Educational Institution of Higher Professional Education, ChSMA. In December 2013, he defended his doctoral dissertation on the topic of "Pathogenesis of Cardiovascular Disorders in Chronic Prostatitis". For over 20 years, he has been a practicing physician in the specialties of therapy, cardiology, and functional diagnostics; for a long time, he worked as a cardiologist in the resuscitation and intensive care unit of City Clinical Hospital No. 1 (Chita), in the cardiology department of City Clinical Hospital No. 1 (Chita), and in the diagnostic polyclinic of the ChSMA Clinic. Currently, he is a cardiologist consultant at the faculty clinics of Irkutsk State Medical University and the Professorial Clinic of Irkutsk State Medical University. In 2017, he was awarded the academic title of Associate Professor in the specialty "Internal Medicine". In 2024, he was awarded the academic title of Professor in the specialty "Internal Medicine". Doctor of the highest qualification category in the specialty "Cardiology". More than 250 scientific papers have been published in various publications, he is the author of 2 monographs, co-author of 14 educational and teaching aids, 3 patents for invention, 7 certificates for computer programs.
Main scientific works:
1. Vasilenko P.V. The role of some genetic polymorphisms in the development of sudden cardiac death in the Trans-Baikal Territory / P.V. Vasilenko, D.N. Zaitsev D.N. // Siberian Medical Review. - 2021. - No. 2. - P. 35-42.
2. Vasilenko P.V. Results of the registry of sudden cardiac death of the population of the Trans-Baikal Territory (ZODIAC*) 2017-2019 / P.V. Vasilenko, D.N. Zaitsev et al. // Russian Journal of Cardiology. - 2020; Vol. 25, No. 11. - P. 108-114.
3. Kalashnikova N.M. The first results of the hospital registry of patients with chronic ischemic heart disease, arterial hypertension and chronic heart failure in the Trans-Baikal Territory / N.M. Kalashnikova, D.N. Zaitsev // Trans-Baikal Medical Bulletin - 2020. - No. 4. - P. 33-37.
4. Ma-Wang-de V.D. Clinical and laboratory markers of the severity of the new coronavirus infection (COVID-19) / V.D. Ma-Wan-de, D.N. Zaitsev, et al. // Siberian Medical Review. - 2022. - No. 3. - P. 40-48.
5. Kalashnikova N.M. Features of post-infarction chronic heart failure in patients with a new coronavirus infection COVID-19 / N.M. Kalashnikova, D.N. Zaitsev // Kazan Medical Journal. - 2023. - No. 1. - P. 20-29.
6. Slobodskaya I.V., Zaitsev D.N. Vasilenko P.V. Prevalence of severe hypercholesterolemia and lipid-lowering therapy in patients with acute coronary syndrome and ischemic stroke in the Regional Vascular Center of Chita / I.V. Slobodskaya, D.N. Zaitsev, P.V. Vasilenko // Atherosclerosis and dyslipidemia. - 2023. - No. 2. P. 28-36.
7. Vasilenko P.V., Zaitsev D.N., Mudrov P.V. Program for determining the risk of sudden cardiac death / Certificate of state registration of the computer program No. 2021619436.
8. Ma-Wan-de V.D., Zaitsev D.N., Mukha N.V., Mudrov V.A. Program for early diagnosis of severe community-acquired pneumonia in COVID-19 / Certificate of state registration of the computer program No. 2021668062.
9. Kalashnikova N.M., Zaitsev D.N., Tereshkov P.P., Mudrov V.A. Program for assessing the probability of an adverse cardiovascular event within a year in patients with chronic heart failure / Certificate of state registration of the computer program No. 2022682195.
10. Zaitsev D.N., Govorin A.V. Cardiovascular disorders in chronic prostatitis // Chita: RIC ChSMA, 2018. - 126 p. (monograph).
11. Vasilenko P.V., Zaitsev D.N. Sudden cardiac death in the Trans-Baikal Territory // Irkutsk: Publishing House of Irkutsk State University, 2023. - 99 p. (monograph).
Currently, under the supervision of D.N. Zaitsev, 3 candidate dissertations have been defended, 1 doctoral and 2 candidate dissertations are in progress. The area of scientific interests is cardiology, lipidology. The area of scientific interests of students is registry studies: Registry of persons who died from the mechanism of sudden cardiac death; Registry of persons infected with COVID-19; Registry of patients with familial hypercholesterolemia and patients with very high cardiovascular risk with insufficient effectiveness of lipid-lowering therapy.
In September 2022, the Center for Atherosclerosis and Lipid Metabolism Disorders (Lipid Center) was created at the Clinic of the Chita State Medical Academy under the supervision of D.N. Zaitsev.
International and Russian clinical trials in which D.N. Zaitsev participated. as Principal Investigator and Co-Investigator:
GS-US-259-0147 International Study “A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Phase III Study to Evaluate the Efficacy and Safety of Ranolazine Added to Metformin Therapy in Patients with Type 2 Diabetes Mellitus”
GS-US-259-0110 “A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Phase III Study to Evaluate the Efficacy and Safety of Ranolazine Added to Glimepiride Therapy in Patients with Type 2 Diabetes Mellitus”.
GS-US-259-0131 “A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Phase 3 Study to Evaluate the Efficacy and Safety of Ranolazine Monotherapy in Patients with Type 2 Diabetes Mellitus type”.
GS-US-259-0108 “A randomized, double-blind, placebo-controlled, phase 4 study in parallel groups on the use of Ranolazine in patients with coronary artery disease, angina pectoris and type II diabetes mellitus”.
ARISTOTLE An international clinical randomized, double-blind, phase 3 study in parallel groups with active control (warfarin) to evaluate the efficacy and safety of apixaban as a means of preventing stroke and systemic embolism in patients with non-valvular atrial fibrillation.
RIVAROXHFA3001 "A randomized, double-blind, multicenter, event-based trial to evaluate the efficacy and safety of oral rivaroxaban versus placebo in reducing the risk of death, myocardial infarction, or stroke in patients with chronic heart failure and advanced coronary artery disease after hospitalization for worsening heart failure (COMMANDER HF)
GEMINI-ACS-1 A randomized, double-blind, active-controlled, parallel-group, multicenter trial to compare the safety of rivaroxaban versus aspirin in addition to clopidogrel or ticagrelor in acute coronary syndrome
CRLX030A3301 "A multicenter, prospective, randomized, open-label comparative study of serelaxin versus standard therapy in patients with acute heart failure”, Phase IIIb
“A randomized, double-blind, phase 3 study to evaluate the safety and efficacy of tenofovir alafenamide (TAF) 25 mg once daily versus tenofovir disoproxil fumarate (TDF) 300 mg once daily in the treatment of HBeAg-positive (0110) chronic hepatitis B”.
“A randomized, double-blind, phase 3 study to evaluate the safety and efficacy of tenofovir alafenamide (TAF) 25 mg once daily versus tenofovir disoproxil fumarate (TDF) 300 mg once daily in the treatment of HBeAg-negative (0108) chronic hepatitis B”.
Registry of patients with familial hypercholesterolemia and patients with very high cardiovascular risk with insufficient effectiveness of lipid-lowering therapy "RENAISSANCE".
Registry "AKTIV4" "Analysis of the dynamics of comorbid diseases in patients who have suffered SARS-CoV-2 infection during the fourth wave of COVID-19".
Membership in scientific communities: I am currently the Chairman of the Association "Transbaikal Society of Cardiologists", a member of the board of the Russian Cardiological Society.
Work in scientific journals: member of the editorial board of the journal "Baikal Medical Journal", member of the editorial board of the journal "Far Eastern Medical Journal".
Awards: awarded the Certificate of Honor and Gratitude of the Minister of Health of the Russian Federation, Certificates of Honor of the Governor of the Transbaikal Territory, the Mayor of Chita, the rector's office of the Chita State Medical Academy, awarded the "Excellent Healthcare Worker" badge. In 2021, he became a laureate of the “Man of Labor” project of the interregional charitable foundation “Zemlyaki”.
Currently, along with acting as the head of the basic department of the FSBEI HE Irkutsk State Medical University, he is the director of the Research Institute of Biomedical Technologies of Irkutsk State Medical University, professor of the department of endocrinology and clinical pharmacology
